Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Esophageal Cancer|Gastric Cancer|Lung Cancer|Pancreatic Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BIOLOGICAL: ALVAC-CEA vaccine|BIOLOGICAL: aldesleukin|BIOLOGICAL: sargramostim|BIOLOGICAL: vaccinia-CEA vaccine
Sponsor: Georgetown University
Collaborators: National Cancer Institute (NCI)